Furthermore, a targeted therapy that antagonizes the downstream signaling of the epidermal growth factor receptor (EGFR) has been proved to have synergy with radiotherapy in the treatment of mouth cancer 2. This evidence concerns the gene EGFR and oral cavity neoplasm.